ConagenConagen’s strain development, fermentation, and scale-up technologies deliver products which enhance the sales, production and profitability of our global partners across a broad spectrum of current and developing markets including pharmaceuticals. Our new proprietary microbial platform is enabled with faster, better and cheaper production of vaccines. Monoclonal antibodies and biopharmaceuticals for a wide range of therapeutic areas.